MK0431

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for MK0431, covering 2010-04-02 to 2017-03-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK0431 in Patients With Type 2 Diabetes (0431-010) [Phase 2]